Yu et al. reported that 1-methy1-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mice exhibited marked TH reduction in both the SN and striatal regions, accompanied by distinct regional alterations in the m6A regulatory proteins [52]. This evidence concerns the gene PROS1 and Parkinson disease.